Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genome-wide association study identifies three loci associated with melanoma risk

Abstract

We report a genome-wide association study of melanoma conducted by the GenoMEL consortium based on 317K tagging SNPs for 1,650 selected cases and 4,336 controls, with replication in an additional two cohorts (1,149 selected cases and 964 controls from GenoMEL, and a population-based case-control study in Leeds of 1,163 cases and 903 controls). The genome-wide screen identified five loci with genotyped or imputed SNPs reaching P < 5 × 10−7. Three of these loci were replicated: 16q24 encompassing MC1R (combined P = 2.54 × 10−27 for rs258322), 11q14-q21 encompassing TYR (P = 2.41 × 10−14 for rs1393350) and 9p21 adjacent to MTAP and flanking CDKN2A (P = 4.03 × 10−7 for rs7023329). MC1R and TYR are associated with pigmentation, freckling and cutaneous sun sensitivity, well-recognized melanoma risk factors. Common variants within the 9p21 locus have not previously been associated with melanoma. Despite wide variation in allele frequency, these genetic variants show notable homogeneity of effect across populations of European ancestry living at different latitudes and show independent association to disease risk.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Results of Cochran-Armitage (CA) trend test for all SNPs passing quality control reported as −log10 P values.
Figure 2: Stratified CA trend tests.
Figure 3: Forest plot of associations by geography and case category.

Similar content being viewed by others

References

  1. Cannon-Albright, L.A., Bishop, D.T., Goldgar, C. & Skolnick, M.H. Genetic predisposition to cancer. in Important Advances in Oncology (eds. DeVita, V.T., Hellman, S. & Rosenberg, S.A.) 39–55 (J. B. Lippincott & Co., Philadelphia, 1991).

    Google Scholar 

  2. Bataille, V. et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br. J. Cancer 73, 1605–1611 (1996).

    Article  CAS  Google Scholar 

  3. Chang, Y.M. et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int. J. Cancer 124, 420–428 (2009).

    Article  CAS  Google Scholar 

  4. Hollenbeak, C.S. et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 104, 1962–1967 (2005).

    Article  Google Scholar 

  5. Naldi, L. et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann. Epidemiol. 15, 545–550 (2005).

    Article  Google Scholar 

  6. Titus-Ernstoff, L. et al. Pigmentary characteristics and moles in relation to melanoma risk. Int. J. Cancer 116, 144–149 (2005).

    Article  CAS  Google Scholar 

  7. Holly, E.A., Aston, D.A., Cress, R.D., Ahn, D.K. & Kristiansen, J.J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am. J. Epidemiol. 141, 923–933 (1995).

    Article  CAS  Google Scholar 

  8. Holly, E.A., Aston, D.A., Cress, R.D., Ahn, D.K. & Kristiansen, J.J. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am. J. Epidemiol. 141, 934–942 (1995).

    Article  CAS  Google Scholar 

  9. Raimondi, S. et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int. J. Cancer 122, 2753–2760 (2008).

    Article  CAS  Google Scholar 

  10. Kanetsky, P.A. et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 66, 9330–9337 (2006).

    Article  CAS  Google Scholar 

  11. Gudbjartsson, D.F. et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886–891 (2008).

    Article  CAS  Google Scholar 

  12. Elwood, J.M. & Jopson, J. Melanoma and sun exposure: an overview of published studies. Int. J. Cancer 73, 198–203 (1997).

    Article  CAS  Google Scholar 

  13. Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8, 23–26 (1994).

    Article  CAS  Google Scholar 

  14. Berwick, M. et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol. Biomarkers Prev. 15, 1520–1525 (2006).

    Article  CAS  Google Scholar 

  15. Goldstein, A.M. et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J. Med. Genet. 44, 99–106 (2007).

    Article  CAS  Google Scholar 

  16. Bishop, J.A. et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J. Invest. Dermatol. 114, 28–33 (2000).

    Article  CAS  Google Scholar 

  17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).

  18. Novembre, J. et al. Genes mirror geography within Europe. Nature 456, 98–101 (2008).

    Article  CAS  Google Scholar 

  19. Han, J. et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 4, e1000074 (2008).

    Article  Google Scholar 

  20. Pasmant, E. et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963–3969 (2007).

    Article  CAS  Google Scholar 

  21. Brown, K.M. et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet. 40, 838–840 (2008).

    Article  CAS  Google Scholar 

  22. Falchi, M et al. Genome-wide association study identifies loci at 9p21 and 22q13 associated with development of cutaneous nevi. Nat. Genet. advance online publication, doi:10.1038/ng.410 (5 July 2009).

  23. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).

    Article  CAS  Google Scholar 

  24. Antoniou, A.C. & Easton, D.F. Polygenic inheritance of breast cancer: implications for design of association studies. Genet. Epidemiol. 25, 190–202 (2003).

    Article  Google Scholar 

  25. Puig, S. et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J. Clin. Oncol. 23, 3043–3051 (2005).

    Article  CAS  Google Scholar 

  26. Baxter, A.J. et al. The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures. Twin Res. Hum. Genet. 11, 183–196 (2008).

    Article  Google Scholar 

  27. Whiteman, D.C. et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 57, 173–180 (2008).

    Article  CAS  Google Scholar 

  28. Landi, M.T. et al. Genetic susceptibility in familial melanoma from northeastern Italy. J. Med. Genet. 41, 557–566 (2004).

    Article  CAS  Google Scholar 

  29. Pastorino, L. et al. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pigment Cell Melanoma Res. 21, 700–709 (2008).

    Article  CAS  Google Scholar 

  30. Newton Bishop, J.A. et al. Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br. J. Cancer 80, 295–300 (1999).

    Article  CAS  Google Scholar 

  31. Borg, A. et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J. Natl. Cancer Inst. 92, 1260–1266 (2000).

    Article  CAS  Google Scholar 

  32. Chaudru, V. et al. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J. Natl. Cancer Inst. 96, 785–795 (2004).

    Article  Google Scholar 

  33. Platz, A. et al. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J. Natl. Cancer Inst. 89, 697–702 (1997).

    Article  CAS  Google Scholar 

  34. Holland, E.A. et al. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 11, 2289–2294 (1995).

    CAS  PubMed  Google Scholar 

  35. Holland, E.A., Schmid, H., Kefford, R.F. & Mann, G.J. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosom. Cancer 25, 339–348 (1999).

    Article  CAS  Google Scholar 

  36. Debniak, T. et al. Common variants of DNA repair genes and malignant melanoma. Eur. J. Cancer 44, 110–114 (2008).

    Article  CAS  Google Scholar 

  37. Peric, B. et al. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. BMC Med. Genet. 9, 86 (2008).

    Article  Google Scholar 

  38. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).

    Article  CAS  Google Scholar 

  39. Patterson, N., Price, A.L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).

    Article  Google Scholar 

  40. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

    Article  CAS  Google Scholar 

  41. Clayton, D. Testing for association on the X chromosome. Biostatistics 9, 593–600 (2008).

    Article  Google Scholar 

  42. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was funded by the European Commission under the 6th Framework Programme, contract no: LSHC-CT-2006-018702, by Cancer Research UK Programme Award (C588/A4994) and by US National Institutes of Health R01 ROI CA83115. Work at CNG was supported by the Ministère de l'Enseignement Supérieur et de la Recherche and Institut National du Cancer (INCa).

This study was also supported by the following: research grant no. C-20070050 from the Israel Cancer Association, the Intramural Research Program of the NIH, National Cancer Institute, Division of Cancer Epidemiology and Genetics, and by National Cancer Institute grants RO1 CA5558 to M.T.L. Grants 03/0019 and 06/0265 from Fondo de Investigaciones Sanitarias; grant RO-1 CA 83115 (fund 538226 from National Cancer Institute); Francisco Cuellar from CONACYT, Mexico, 2007 Italian Ministry of Health DGRST.4/4235-P1.9.A.B to G.B.-S., the Swedish Cancer Society, Kamprad Foundation, Lund Hospital Fund, National Institutes of Health (#CA88363), The Swedish Cancer Society (Grant No: 4860-B06-04XBC), The Swedish Research Council (Grant No: K2006-74X-20141-01-3) and the Radiumhemmet Research Funds. Grants from Institut National du Cancer (INCa-PL016) and Ligue Nationale contre le Cancer (PRE2005.LNCC/FD) to F.D., PHRC2007 (AOM-07-195) to M.-F.A. and F.D., grant from Institut National du Cancer (Melanoma Network RS Number 13) to B.B.-deP. This work was developed in the Melanoma Unit of Hospital Clinic I Provincial de Barcelona, IDIBAPS. Ascertainment and data collection in Sydney and the Australian Melanoma Family Study (AMFS) was supported by NHMRC grants 107359, 200071 and 402761 and grants from Cancer Councils of NSW, Victoria and Queensland and the Cancer Institute NSW. J.H. is an Australia Fellow of the NHMRC. This work was supported by the Intramural Program at the National Human Genome Research Institute, National Institutes of Health. Funding was provided by NIH National Cancer Institute grant RO1 CA102422 (to L.A.C.-A.).

The Principal Investigators of Q-MEGA would like to thank D. Statham, M. de Nooyer, I. Gardner and B. Haddon for project management; A. Henders, M. Campbell and M. Stark for managing sample processing and preparation; D. Smyth and H. Beeby for data management and J. Palmer and J. Simmons for ascertainment of clinical records. We also thank the numerous interviewers who collected questionnaire data. Most of all we thank the individuals with melanoma and their families for their cooperation.

The Sydney and AMFS investigators are grateful to all members of the recruitment, data collection and laboratory team, especially C. Watts, R. Dalziell, K. Mahendran, G. St. George and C. Agha-Hamilton and AMFS coordinators J. Maskiell, M. Ferguson and J. Jettan.

This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data are available from the Wellcome Trust website. Funding for the project was provided by the Wellcome Trust under award 076113.

The authors thank the EGEA cooperative group for having given access to data on the EGEA (Epidemiological study on the Genetics and Environment of Asthma) study. Biological specimens of the French Family study group were obtained from IGR Biobank.

The authors are grateful for the contributions of P.A. Van Belle to the work of GenoMEL. The authors would also like to thank D. Seminara.

Author information

Authors and Affiliations

Authors

Contributions

D.T.B. led the analysis group, contributed to the design of the study and was a member of the writing team; F.D. advised on analysis, contributed to the design of the study and was a member of the writing team; M.M.I. and J.H.B. advised on and carried out analyses, contributed to the design of the study and were members of the writing team; M.H. contributed to the design of the study and contributed genotyping information; J.C.T. and E.C. carried out analyses and were members of the writing team; J.R.-M., T.C-a-W. and D.Z. contributed to the interpretation of genotyping data; J.F.A., M.-F.A., D.C., G.G.-H., V.H., C.I., J.Lang, J.M., N.G.M., G.W.M. and S.N. contributed to the identification of suitable samples for the study; E.A., P.G., M.T.L. and R.M. contributed to the design of the study and contributed to the identification of suitable samples for the study; B.B. contributed to the design of the study and supervised the initial processing of samples; G.B.-S., B.B-deP., L.A.C.-A., T.D., I.G., J.H., M.H., J.L.H., R.F.K., J.Lubiński, G.J.M., F.A.vanN., H.O., S.P., W.vanW., K.M.B., P.G. and D.E.E. contributed to the design of the study; P.A.K., N.K.H. contributed to the design of the study, contributed to the interpretation of genotyping data and advised the analysis group; M.W. contributed to the design of the sample handling process; A.M.G. and E.M.G. advised on study design and statistical analysis; A.B. contributed genotyping information; N.A.G. contributed to the design of the study and was project deputy lead; G.M.L. contributed to the design of the study and the interpretation of genotyping data; J.A.N.B. led the study design group and was overall project leader.

Corresponding author

Correspondence to D Timothy Bishop.

Supplementary information

Supplementary Text and Figures

Supplementary Note, Supplementary Tables 1–4 and Supplementary Figures 1–3 (PDF 2045 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bishop, D., Demenais, F., Iles, M. et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41, 920–925 (2009). https://doi.org/10.1038/ng.411

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.411

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing